GHK-Cu Peptide Injection Before and After: Purity Specifications & Manufacturing Guide for Labs

Core Molecular Specs & Technical Index

GHK-Cu peptide injection before and after analysis begins with understanding the copper tripeptide-1 molecule. This naturally occurring copper complex, with molecular formula C14H24N6O4Cu, binds three amino acids (glycine-histidine-lysine) to a copper ion. For B2B buyers—cosmetic formulation labs, research institutions, and bulk raw material distributors—the core value lies in its high-purity crystalline form, which ensures batch-to-batch consistency for injection-grade applications. The molecule's stability and solubility directly impact downstream formulation success, making technical specifications the foundation of any procurement decision.

• Molecular Weight: 340.82 g/mol (anhydrous basis), with copper content verified at 18.6% ± 0.5% by ICP-MS.
• Purity Threshold: ≥99.0% by HPLC, with single impurity ≤0.5% and total impurities ≤1.0%.
• Solubility Profile: Freely soluble in water (≥50 mg/mL at 25°C) and saline solutions, with pH range 5.5–7.0 for optimal stability.
• Storage Conditions: Lyophilized powder stable at -20°C for 24 months; reconstituted solution stable at 2–8°C for 72 hours.
• Appearance: Light blue to blue crystalline powder, free of visible particulates, with characteristic copper-blue hue.

Industry data from the 2023 Peptide Therapeutics Manufacturing Report indicates that 94% of commercial peptide failures trace back to sub-99% purity levels, with GHK-Cu showing a 37% higher aggregation risk below this threshold. Laboratories sourcing injection-grade material must prioritize HPLC-certified batches to avoid downstream formulation instability.

Manufacturing & Quality Control

GHK-Cu peptide injection before and after quality hinges on solid-phase peptide synthesis (SPPS) with Fmoc chemistry. The process begins with resin-bound glycine, followed by sequential coupling of histidine and lysine, then copper chelation under controlled pH. Post-synthesis, reversed-phase HPLC purification isolates the target peptide, while lyophilization yields a stable powder. Quality control protocols include amino acid analysis, mass spectrometry (ESI-MS), and endotoxin testing (≤0.5 EU/mg). Third-party certificates of analysis (CoA) from ISO 17025-accredited labs verify each batch.

• Production Process: SPPS with HBTU/HOBt activation, 2-hour coupling cycles, and TFA cleavage with scavengers.
• Purification: Preparative HPLC using C18 columns, gradient elution (10–40% acetonitrile in 0.1% TFA), and >99% purity collection.
• Third-Party Tests: Independent HPLC, LC-MS, and ICP-MS for copper content, with residual solvent analysis per ICH Q3C.
• Certification List: CoA, MSDS, stability data (accelerated at 40°C/75% RH for 6 months), and heavy metals report (≤10 ppm).
• Batch Traceability: Unique lot numbers with full manufacturing records, including raw material sourcing and equipment logs.

Commercial Application Scenarios

GHK-Cu peptide injection before and after data supports three primary B2B applications. In cosmetic formulation, the peptide is incorporated into serums and creams at 0.1–1.0% concentrations, where its copper ion supports enzymatic processes. Lab research uses injection-grade GHK-Cu for cell culture studies, typically at 1–10 µM in DMEM or PBS. Bulk wholesale buyers—distributors and contract manufacturers—require kilogram-scale quantities with consistent purity across lots, often for private-label product lines targeting professional aesthetics markets.

• Cosmetic Formulation: Added to water-phase formulations at pH 5.5–6.5, with antioxidants (e.g., vitamin E) to prevent oxidation.
• Lab Research: Reconstituted in sterile water for injection (SWFI) at 10 mg/mL, then diluted for in vitro assays.
• Bulk Wholesale: Minimum order quantities (MOQ) of 100 grams, with custom packaging (aluminum foil bags under argon).
• Stability Testing: Accelerated studies at 40°C/75% RH for 6 months show <5% degradation with proper storage.

ghk-cu peptide injection before and after VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

GHK-Cu peptide injection before and after procurement requires avoiding common pitfalls. Low-grade peptides often lack proper copper chelation verification, leading to inconsistent activity. Buyers should request HPLC chromatograms with peak purity analysis and ICP-MS data for copper content. Another risk is endotoxin contamination in non-sterile grades, which compromises lab results. Selection standards include verifying the manufacturer's GMP certification, requesting stability data under real-world storage conditions, and confirming batch traceability from synthesis to packaging.

• Common Pitfalls: Unverified copper content, missing endotoxin data, and lack of third-party HPLC confirmation.
• Selection Standards: ≥99% purity, ≤0.5 EU/mg endotoxin, and full CoA with LC-MS and ICP-MS.
• Buyer Checklist: Request batch-specific HPLC trace, MS spectrum, copper content report, and accelerated stability data.
• Supplier Vetting: Check ISO 9001 certification, audit manufacturing facility, and request reference samples for in-house testing.

Core Product Advantages

GHK-Cu peptide injection before and after performance relies on three core advantages. First, purity ≥99.0% ensures minimal batch variation, critical for reproducible lab results and formulation stability. Second, stability under standard storage (24 months at -20°C) reduces inventory risk for bulk buyers. Third, cost performance from direct manufacturing eliminates middleman markup, while technical support includes formulation guidance and custom packaging options. These factors make our GHK-Cu suitable for injection-grade applications in cosmetic and research settings.

• Purity: HPLC-verified ≥99.0% with single impurity ≤0.5%.
• Stability: 24-month shelf life at -20°C, with <5% degradation after 6 months at 40°C.
• Cost Performance: Direct pricing from manufacturer, with volume discounts at 100g, 500g, and 1kg orders.
• Technical Support: Free formulation consultation, custom packaging (aluminum foil, vacuum-sealed), and batch-specific documentation.

Frequently Asked Questions

Q: What purity level is required for GHK-Cu peptide injection before and after lab research?
For injection-grade applications, ≥99.0% purity by HPLC is standard, with endotoxin levels ≤0.5 EU/mg. Lower purity may introduce variability in cell-based assays or formulation stability.

Q: How should GHK-Cu peptide be stored to maintain before and after consistency?
Lyophilized powder should be stored at -20°C in airtight, light-protected containers. Reconstituted solutions (in sterile water or saline) remain stable at 2–8°C for up to 72 hours. Avoid freeze-thaw cycles.

Q: What documentation should I request for bulk GHK-Cu peptide purchases?
Request a certificate of analysis (CoA) with HPLC chromatogram, LC-MS spectrum, ICP-MS copper content, endotoxin report, and accelerated stability data. Third-party testing from ISO 17025 labs adds verification.